Welcome to the website of EFIS

News

Travel Grants for ALACI 2024!

EFIS is pleased to offer up to five travel grants of EUR 1000 each to EU-based early career researchers* and members of EFIS-affiliated societies wishing to attend the 14th Congress of the Latin American and Caribbean Immunology - ALACI 2024 - to be held 4-8 November 2024 in Buenos Aires, Argentina.

*MSc and PhD students or postdocs with no more than 7 years postdoctoral experience (excluding career interruptions)

Applicants must submit via email to office@efis.org:

1) Proof of membership in an EFIS-affiliated society,
2) Proof of registration to ALACI 2024,
3) The abstract(s) submitted to ALACI 2024.

Grantees will be informed of their awards by 15 September 2024.

Address any questions to: office@efis.org

Deadline: 18 August 2024

read more >>

NEWS FROM OUR OFFICIAL JOURNALS

European Journal of Immunology

RAG1/2 induces double‐stranded DNA breaks at non‐Ig loci in the proximity of single sequence repeats in developing B cells


Reverse aging to treat lupus


Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes


Langerhans cells and skin immune diseases


Identification and structural characterization of a mutant KRAS‐G12V specific TCR restricted by HLA‐A3


Tridecylcyclohexane in incomplete Freund's adjuvant is a critical component in inducing experimental autoimmune diseases


Functional Fc receptors are crucial in antibody‐mediated protection against cytomegalovirus


PD‐1 regulation of pathogenic IL‐17‐secreting γδ T cells in experimental autoimmune encephalomyelitis


The complement system as a target in cancer immunotherapy


Interferon α and β induce differential transcriptional and functional metabolic phenotypes in human macrophages and blunt glycolysis in response to antigenic stimuli


Immunology Letters

Proteasome isoforms in human thymi and mouse models


Immunoregulatory properties of melatonin in the humoral immune system: A narrative review


Cataloging circulating CD3+CD56+ NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma


Vitamin D3 attenuates autoimmune thyroiditis by regulating Th17/Treg cell differentiation via YAP/JAK1/STAT1 axis


Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp


Gut dysbiosis impacts the immune system and promotes prostate cancer


Pathophysiology of cutaneous T-cell lymphomas: Perspective from a French referral centre


The Th1/Th2 paradigm: A misrepresentation of helper T cell plasticity


Corrigendum to “Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a” [Immunology Letters 250 (2022) 29–40 on Sep 13, 2022/ Manuscript ID: IMLET-D-22-00159R2, PMID: 36108773]


Dysregulated Th17/Treg cell axis is correlated with local and systemic immune response in human intermediate uveitis